Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chit

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|October 25, 2013
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in CanadaT E Delea, J Amdahl, A Chit, et al.
Vaccine|July 16, 2014
Examining Ontario's universal influenza immunization program with a multi-strain dynamic modelE W Thommes, A Chit, G C Meier, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United StatesP T De Boer, R J Pitman, B Macabeo, et al.
Current Oncology (Toronto, Ont.)|December 10, 2014
Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in CanadaT E Delea, J Amdahl, H R Nakhaipour, et al.
Vaccine|October 24, 2020
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industryL Coudeville, G B Gomez, O Jollivet, et al.
Journal of Medical Microbiology|July 3, 2019
Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adultsJ J LeBlanc, M ElSherif, S Mulpuru, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|October 25, 2013
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in CanadaT E Delea, J Amdahl, A Chit, et al.
Vaccine|July 16, 2014
Examining Ontario's universal influenza immunization program with a multi-strain dynamic modelE W Thommes, A Chit, G C Meier, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United StatesP T De Boer, R J Pitman, B Macabeo, et al.
Current Oncology (Toronto, Ont.)|December 10, 2014
Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in CanadaT E Delea, J Amdahl, H R Nakhaipour, et al.
Vaccine|October 24, 2020
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industryL Coudeville, G B Gomez, O Jollivet, et al.
Journal of Medical Microbiology|July 3, 2019
Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adultsJ J LeBlanc, M ElSherif, S Mulpuru, et al.
Pageof 1